Dr. Mujib Ullah has completed his PhD in tissue engineering/regenerative medicine, and postdoctoral studies from Stanford University School of Medicine. Dr Ullah is the medical investigator in the Department of Regenerative Medicine, Stanford University. Previously he worked in Harvard University and MIT. He is editor-in-chief for Artificial Intelligence in Cancer, guest editor for ACS Nano, and section editor for Stem Cells Research and Therapy and Nature. He has published numerous papers and has served as an editorial board member for many journals, such as the American Journal of Bioscience and Bioengineering. Dr Ullah has designed many labs, protocols, and study sections. He has mentored many undergraduate, graduate, and postgraduate students. He has supervised and managed many projects and is the advisor for Bio Thinking and Bio Aims Society. He has received many grants, awards, and fellowship in the field of stem cells regeneration and the CPRIT award for Cancer therapies. He has established cell banks for worldwide distribution under NIH and FDA guidelines. He has developed quality assurance protocols for the Food and Drug Administration to monitor stem cell therapies in regenerative medicine.
Title : Molecular imaging and CD9 based nano-sensors promises to deliver a more precise diagnosis in clincial applicatons